Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutation.

求助中 10 由 CS 发布于 2024/12/25 11:27:32

DOI:10.1182/blood.2024026781
作者：Wei Li,?Ruiui Wang,?Junhao Wang,?Dafei Chai,?Xiaohui Xie,?Ken H H Young,?Ya Cao,?Yong Li,?Xinfang Yu
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1182/blood.2024026781

American Society of Hematology (ASH)

Abstract：Myeloid differentiation primary response protein 88 (MYD88) is a key adaptor molecule in the signaling pathways of toll-like receptor (TLR) and interleukin-1 receptor (IL-1R). A somatic muta

应助信息

等您来应助

上传文件

23小时前

Book学术机器人

2024/12/25 11:27:32 未找到该文献，机器人已退出，请等待人工下载

2024/12/25 11:27:32 Book学术AI机器人收到请求，开始寻找文献

2024/12/25 11:27:32 已向机器人发送请求

23小时前

CS 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:SageA Drug Repositioning Approach Reveals Ergotamine May Be a Potential Drug for the Treatment of Alzheimer's Disease.